Effectiveness Analysis of Armeo Spring Device as a Rehabilitation Treatment in Spinal Cord Injured Patients
Launched by HOSPITAL NACIONAL DE PARAPLÉJICOS DE TOLEDO · May 7, 2020
Trial Information
Current as of May 25, 2025
Completed
Keywords
ClinConnect Summary
In the literature, there are several studies of the upper limb applied to ADL. The analysis of complete ADL is related to the clinical objectives of the rehabilitative treatment of the UL. An important part of rehabilitation after neurological injuries consists of training activities aimed at fulfilling a function or objective, in which patients have to move their arms continuously repeating certain movement patterns. This is currently one of the main strategies to promote recovery of upper limb function in people who have suffered a spinal cord injury (SCI) o stroke.
Within the clinical s...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Cervical lesions above C8, incomplete in the motor aspect or complete with zones of partial motor preservation at least C6, classified according to the ASIA scale.
- • Traumatic or non-progressive medical etiology.
- • Less than 6 months of injury evolution (subacute).
- • Age between 16 and 75 years.
- • To have reached the seated posture.
- • Be informed and consent to participate in the study.
- Exclusion Criteria:
- • Unstable orthopaedic injuries such as unconsolidated fractures or with unstable osteosynthesis systems in upper limbs.
- • Skin lesions and/or pressure ulcers in the exoskeleton placement area.
- • Having joint stiffness and/or severe spasticity.
- • Bronchopneumopathy and/or severe heart disease that will require monitoring during exercise.
- • Visual problems.
- • Cognitive impairment.
- • Do not sign the corresponding informed consent.
About Hospital Nacional De Parapléjicos De Toledo
The Hospital Nacional de Parapléjicos de Toledo is a leading Spanish healthcare institution specializing in the comprehensive rehabilitation of individuals with spinal cord injuries and related conditions. Renowned for its multidisciplinary approach, the hospital integrates advanced medical care, cutting-edge research, and innovative therapeutic techniques to enhance patient outcomes and quality of life. As a prominent clinical trial sponsor, the hospital is dedicated to advancing medical knowledge and treatment options through rigorous clinical research, fostering collaboration with academic institutions and industry partners to translate scientific discoveries into effective interventions for patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Toledo, , Spain
Patients applied
Trial Officials
Ana de los Reyes, PhD
Principal Investigator
Hospital Nacional de Parapléjicos
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials